%0 Journal Article
%T Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma
%A Christel Herold-Mende
%A Denis Migliorini
%A Eliana Marinari
%A Giulia Ranzanici
%A Hideho Okada
%A Johannes Alexander Lobrinus
%A Joseph Costello
%A Paul R. Walker
%A Pierre-Yves Dietrich
%A Shahan Momjian
%A Toni Weinschenk
%A Val¨Śrie Dutoit
%A Val¨Śrie Widmer
%J Archive of "Oncoimmunology".
%D 2018
%R 10.1080/2162402X.2017.1391972
%K grade II glioma
%K grade III glioma
%K immunotherapy
%K peptide vaccine
%K IMA950
%K spontaneous T cell responses
%K astrocytoma
%K oligodendroglioma
%K ependymoma
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749651/